Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04181476

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the efficacy of topical products in providing protection against the visible light and ultraviolet A1 (UVA1) part of sunlight. Ultraviolet radiation and visible light are both components of sunlight that reach the earth. It is important to test these topical products against visible light and UVA1 because our current sunscreens may not protect against these very well.

Conditions

Interventions

TypeNameDescription
DRUGSunscreening AgentsFour different sunscreens

Timeline

Start date
2019-11-05
Primary completion
2021-01-18
Completion
2022-06-01
First posted
2019-11-29
Last updated
2022-01-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04181476. Inclusion in this directory is not an endorsement.